Paul F. Truex, President and CEO at Anthera Pharmaceuticals Inc (ANTH), sold 20,122 shares at $8.30 ($125K) on 2011-06-15, disclosed to the SEC on 2011-06-17.
Scheduled sale ($125k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,122 | $0 | 0.0% |
| 2 | $8.30 | 15,000 | $125K | 100.0% |
| Total | $6.19 avg | 20,122 | $125K | 100% |
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |